Fibromodulin-Defined Medium for Feeder-Free Pluripotent Stem Cell Reprogramming
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for culturing human pluripotent stem cells face challenges such as reliance on animal products, variability in serum batches, and the need for feeder cells of non-human origin, which complicates the achievement of standardized, serum-free, and feeder-free conditions for cell proliferation and differentiation.
Innovation Solution
A cell culture medium composition containing fibromodulin (FMOD) is used to reprogram mammalian cells into pluripotent stem cell-like clones, recognized by specific markers, allowing for differentiation into various tissue types without the need for animal-derived components or feeder cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If human ES cells are cultured using traditional methods with animal-derived serum and feeder cells, then cell proliferation and maintenance are supported, but the culture conditions lack standardization and introduce variability from batch to batch
Solution Approach 1:
The patent removes animal-derived serum and feeder cells from the culture system, extracting the problematic components that cause batch variability. The defined medium formulation eliminates these variable elements while maintaining essential growth factors and nutrients at controlled concentrations, thereby achieving standardization without sacrificing cell proliferation support
Solution Approach 2:
The invention establishes specific parameter ranges for critical medium components including defined concentrations of growth factors, amino acids, and vitamins. These controlled parameters replace the variable natural components, creating reproducible culture conditions that maintain cell health and proliferation while eliminating batch-to-batch variability
2Reliability
If animal-derived serum and feeder cells are used in human ES cell culture, then cell growth is maintained, but exposure to animal pathogens becomes a risk
Solution Approach 1:
The patent completely removes animal-derived components including fetal bovine serum and feeder layers from the culture system. This extraction eliminates the pathway for animal pathogen transmission while the defined medium formulation maintains all necessary nutritional and growth factors through synthetic or recombinant sources
Solution Approach 2:
The invention introduces a defined medium formulation as an intermediary that provides all necessary growth factors, nutrients, and protective elements previously supplied by animal serum and feeder cells. This synthetic medium acts as a safe intermediary that eliminates pathogen risk while maintaining cell growth and differentiation capabilities
3Reliability
If human ES cells are cultured in defined conditions without animal products, then safety and standardization are improved, but the ability to maintain undifferentiated state becomes more challenging
Solution Approach 1:
The patent optimizes specific parameter ranges for growth factors, cytokines, and extracellular matrix components in the defined medium. These controlled parameters are tuned to maintain the undifferentiated state of human ES cells while eliminating animal-derived variability. The precise control of these parameters enables both safety and differentiation control
Solution Approach 2:
The invention creates a composite defined medium formulation that integrates multiple purified components including growth factors, amino acids, vitamins, and buffer systems. This composite formulation provides the complex signaling environment needed to maintain undifferentiated cells while using only synthetic or recombinant components for safety and standardization
Data Source
Figure 1a~3b
Figure 4~5
Figure 6~7
AI summary
The present invention provides pluripotent stem cell like (PSCL) cells or clones, a culture medium therefore, and a supernatant thereof, and methods of making and using the same.